LINKS
ABOUT
SOCIAL

info@breathevision.com

Tel: +972-(0) 8-672-0512

BreatheVision Ltd.

Kibbutz Yad Mordechai

79145, Israel

  • White LinkedIn Icon
  • White Facebook Icon
  • White Twitter Icon
  • White Google+ Icon

THE FUTURE OF NON-INVASIVE RESPIRATORY MONITORING

01

No tubes. No wires.

Non-invasively monitors patient’s breathing, gives reliable alerts for deteriorating volumes, apnea and obstructive breathing

02

Cost-effective

Monitors breathing at a fraction of the cost of existing monitoring technologies by utilizing off-the-shelf hardware.

03

Intuitive & Simple

Straight-forward to use and interpret by all medical staff. Output consists of standard respiratory parameters.

MEET BREATHEVISION

OUR STORY

BreatheVision was founded in 2013 on the need to develop a simple method for early detection of breathing deterioration in patients under conscious sedation... The founders built on their expertise in machine vision and missile navigation algorithms to invent a way to quantify breathing through analyzing chest micro-movements based on low-cost off the shelf hardware.

OUR VISION

To improve patient safety by monitoring essential breathing parameters through machine learning technology and providing immediate warning.

OUR PRODUCT

Our first product, the SafeSed monitoring system, was developed for medical staff to continuously monitor respiration during sedation procedures, such as colonoscopy.

OUR

TEAM

Menashe Terem, MA
CEO

Former executive at El-Al Airlines who also led several medical device companies into OTC and professional markets worldwide.

Ditza Auerbach, PhD
CTO

Physicist experienced in leading imaging and machine learning R&D at Aspect Imaging and Applied Materials. 

Yulia Krasilshchikov, MSc
Algorithm developer

Vastly experienced in developing biomedical signals processing and diagnostic algorithms for medical device companies.

Prof. Ilan Shimshoni
Scientific Advisor

Professor of Information Systems at the Computer Science Department at Technion, University of Haifa (Israel)

PROSPECTIVE TARGET MARKETS

Endoscopy
procedural
sedation

MEDICAL NEED

Adverse events associated with sedation
“Drug-induced respiratory depression is the primary cause of morbidity associated with sedation and analgesia”
American Society of Gastroenterology Nurses and Associates 2016
Continuous respiratory monitoring

"…hospitals are expected to address monitoring for …respiratory

depression related to opioids for post-operative patients…. monitoring of ventilation may warrant … to assess breathing"

Centers for Medicare & Medicaid Services (CMS), 2014 
Apnea
Obstructive
Shallow

SafeSed- No Tubes, No Wires

Simply Brilliant!​

CLINICAL VALIDATION

BreatheVision performs clinical validation of the SafeSed monitoring system at Meir Medical Center (Kfar Saba, Israel). The clinical trial will evaluate safety and performance of the SafeSed system for monitoring patients undergoing elective gastrointestinal endoscopy. 
The SafeSed system will be compared with conventional methods of respiratory monitoring - capnography and pulse oximetry.
Patient enrollment to the trial will start in November 2016. 
For more information

SafeSed signal vs. capnograph signal

OUR NEWS

2016
1st clinical trial for SafeSed in the Gastro clinic began recruiting at Meir Medical Centre, Israel.

DEC.

2017
1st US Patent granted for the SafeSed system. 

OCT.

Successful FDA Pre-Submission meeting for the SafeSed device

APR.

2018

AUG.

2018
Clinical Validation Trial for Volume determination by SafeSed began recruiting at Meir Medical Centre, Israel. 
 
 
 
 
 
 
 

Respiratory rate

(number of breaths in 

one minute)

Minute ventilation

(total amount of air inhaled or exhaled in one minute)

 Tidal volume

(amount of air moved

with each breath)

Our algorithm analyzes the measured data, alerts on breathing deterioration, and displays continuously the following breathing parameters:

OUR

TECHNOLOGY

SafeSed recognizes deterioration
in patient’s breathing that requires
immediate medical attention.
 

STAY IN TOUCH